This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Psychotropic Drugs Market

Market Insights on Psychotropic Drugs covering sales outlook, demand forecast & up-to-date key trends

Psychotropic Drugs Market By Drug Type, Application, Distribution Channel & Region - Forecast 2022 – 2032

Psychotropic Drugs Market Overview (2022-2032

[250 Pages Report] The global psychotropic drugs market is estimated to exhibit growth at a CAGR of around 6% to 7% over the forecast period 2022-2032. Growing awareness regarding the severity of mental illnesses and increasing introduction of new psychological drugs for safe and effective treatment of psychological disorders is expected to propel the demand for psychotropic drugs in the global market.

Report Attribute

Details

Psychotropic Drugs Market Projected Growth Rate (2022-2032)

7% to 8% CAGR

Psychotropic Drugs Market Estimated Value in the Antipsychotic Segment (2022)

US$ 20 Billion

Psychotropic Drugs Market Forecast Value in the Antipsychotic Segment (2032)

US$ 30 Billion

Antipsychotic Segment Growth Rate (2022-2032)

6% to 7% CAGR

Psychotropic drugs are medications used for an assortment of mental illnesses when they cause a significant impact on the healthy functioning of the body. These drugs are used to alter moods, perception, behavior, thought, and others. It is an umbrella term used for numerous drugs including, therapeutic drugs, prescription drugs, and misused drugs.

Essential psychotropic drugs are classified as the medicine that satisfies the primary mental health care requirements and treat mental conditions such as anxiety, mood swings, and others, of the target population. These drugs are categorized as psychotropic medicines on the basis of their comparative cost-effectiveness of the drug, public health relevance, and evidence of drug safety and efficacy.

These drugs normally work by adjusting the amount of significant chemicals such as serotonin, dopamine, and norepinephrine in the brain called neurotransmitters. Increasing research and development (R&D) activities and introduction of novel drugs have shown improvement in patients with severe psychological disorders. This is anticipated to augment the demand for novel psychotropic drugs in the global market.

Customize this Report

Let us know your requirement to get
100% FREE customization

Which are Some Prominent Drivers Spearheading Psychotropic Drugs Market Growth?

Increasing stressed lifestyle of the population and excess use of alcohol has resulted in a substantial rise in prevalence of mental disorders and illnesses such as epilepsy, depression, dementia, and schizophrenia among others across the globe, creating strong demand for associated therapeutics.

According to a study published by the Anxiety & Depression Association of America, anxiety disorders are considered the most common mental condition in the United States, affecting nearly 40 million adults between the age of 18 and older, or around 18.1% of the overall population across the country every year.

As psychotropic drugs are extensively used for the treatment of aforementioned illnesses, growing burn of such mental disorders is estimated to create high revenue generation opportunities in the global market.

In addition to this, several international, governmental, and regulatory organizations are emphasizing on launching numerous initiatives for the awareness and treatment of mental illnesses to curb the overall burden.

For instance, in 2019, the World Health Organization (WHO) announced launching a special initiative for mental health, “Universal Health Coverage for Mental Health” for ensuring access to affordable and quality care for mental health disorders for around 100 million people across 12 countries. A slew of such initiatives is estimated to accelerate the sales of mental health treatment medication such as psychotropic drugs across the globe.

What are the Challenges Faced by the Psychotropic Drugs Market?

Increasing awareness regarding the side effects due to the consumption of psychotropic drugs such as sleep disturbances, drowsiness, cardiac issues, sexual side effects, fatigue, weight gain, akathisia, tardive dyskinesia, and others is hinder in the sales in the global market.

Implementation of government regulations on the use of antipsychotic drugs in some countries to counter their misuse, and stringent regulatory standards for the launch of novel mental illness treatment medications are restraining the growth in the psychotropic drugs market

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why is North America Emerging as an Opportunistic Psychotropic Drugs Market?

As per FMI, North America is anticipated to emerge as the most remunerative market for psychotropic drugs during the forecast period 2022-2032.

The prevalence of mental illnesses such as epilepsy, primary insomnia, panic disorder, depressive disorder, and dementia across North America is growing at a rapid pace, due to the excessive consumption of alcohol, caffeine, and opioids among the population. Hence, governments of several countries are increasingly undertaking numerous initiatives to strengthen their mental health infrastructure for curbing the burden of mental illness. For instance, the U.S. Government announced providing Mental Health Block Grants (MHBG) to support associated organizations in strengthening their community mental health services. Such initiatives are projected to augment the demand for psychotropic drugs in the global market.

How is Asia Pacific Excluding China & Japan Contributing to the Growth of the Psychotropic Drugs Market?

Future Market Insights reveals that Asia Pacific excluding China & Japan is expected to account for a significant share in the global psychotropic drugs market from 2022 to 2032.

Numerous manufacturers in the market are focusing on research and development activities for the development of more effective and safe mental disorder treatment drugs. Also, to cater to the surging demand for anti-anxiety and anti-depression drugs, key players are aiming at entering into agreements, coloration, and acquisitions to expand their product portfolio.

For instance, in 2022, Sun Pharmaceutical Industries Ltd., an Indian multinational pharmaceutical company announced entering into a licensing agreement with a Denmark-based pharmaceutical company to launch novel anti-depression pills under the brand Vortidiftm in India. A multiplicity of these developments is estimated to favor the sales of psychotropic drugs in the Asia Pacific excluding China & Japan market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Market Competition

Some of the leading players in the psychotropic drugs market are Forest Laboratories, Sun Pharmaceutical Industries Ltd., FUJIFILM Wako Pure Chemical Corporation, Randox Laboratories Ltd., Pfizer Inc., Ely Lilly and Company, Mylan N.V., and others.

The market for psychotropic drugs is highly competitive, due to the large presence of market players, increasing new product launches, and adoption of collaboration, agreement, and acquisition strategies.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 7% to 8% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2015-2020

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Drug Type
  • Application
  • Distribution Channel
  • Region

Countries Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding China & Japan
  • China
  • Japan
  • Middle East and Africa

Key Companies Profiled

Customization

Available Upon Request

Key Segments Profiled in the Psychotropic Drugs Market Survey

By Drug Type:

  • Chlorpromazine
  • Thioridazine
  • Quetiapine
  • Risperidone
  • Clozapine
  • Paroxetine
  • Fluvoxamine
  • Others

By Application:

  • Anti-psychotics
  • Antidepressants
  • Mood Stabilizers (MS)
  • Anti-anxiety (AA)
  • Antiepileptic drugs (AEDs)
  • Hypnotics
  • Stimulants

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding China & Japan
  • China
  • Japan
  • Middle East and Africa

Frequently Asked Questions

Forest Laboratories, Sun Pharmaceutical Industries Ltd., FUJIFILM Wako Pure Chemical Corporation, Randox Laboratories Ltd., Pfizer Inc., Ely Lilly and Company, Mylan N.V., and others are some of the leading players in the prominent psychotropic drugs market.

The global psychotropic drugs market is expected to be dominated by North America the forecast period 2022-2032.

Forest Laboratories, Sun Pharmaceutical Industries Ltd., FUJIFILM Wako Pure Chemical Corporation, Randox Laboratories Ltd., Pfizer Inc., Ely Lilly and Company, Mylan N.V., and others are some of the leading players in the prominent psychotropic drugs market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. Value Chain Analysis

        3.5.1. Profit Margin Analysis

        3.5.2. Service Providers

    3.6. PESTLE and Porter’s Analysis

    3.7. Regulatory Landscape

        3.7.1. By Key Regions

        3.7.2. By Key Countries

    3.8. Regional Parent Market Outlook

4. Global Psychotropic Drugs Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Psychotropic Drugs Market Analysis 2017-2021 and Forecast 2022-2032, By Drug Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Drug Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Drug Type, 2022-2032

        5.3.1. Phenothiazines

        5.3.2. Typical Antipsychotics

        5.3.3. Atypical Antipsychotics

        5.3.4. Selective Serotonin Reuptake Inhibitors (SSRIs)

        5.3.5. Serotonin- Norepinephrine Reuptake Inhibitors (SNRIs)

        5.3.6. Monoamine Oxidase Inhibitors (MAOIs)

        5.3.7. Tricyclic Antidepressants (TCAs)

        5.3.8. Norepinephrine Reuptake Inhibitors

        5.3.9. Atypical Antidepressants

        5.3.10. Serotonin Receptor Antagonists

        5.3.11. Anticholinergics

        5.3.12. Benzodiazepines

        5.3.13. Melatonin Congeners

        5.3.14. Barbiturates

        5.3.15. Dopamine-Receptor Antagonists

        5.3.16. Others

    5.4. Y-o-Y Growth Trend Analysis By Drug Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Drug Type, 2022-2032

Deep-dive segmentation will be available in the sample on request

6. Global Psychotropic Drugs Market Analysis 2017-2021 and Forecast 2022-2032, By Indication

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032

        6.3.1. Depression And Anxiety Disorders

        6.3.2. Psychosis And Mania

        6.3.3. Mood Disorders

        6.3.4. Substance Use

        6.3.5. Insomnia

    6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Indication, 2022-2032

Deep-dive segmentation will be available in the sample on request

7. Global Psychotropic Drugs Market Analysis 2017-2021 and Forecast 2022-2032, By Route of Administration

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By Route of Administration, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Route of Administration, 2022-2032

        7.3.1. Oral

        7.3.2. Parenteral

    7.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2017-2021

    7.5. Absolute $ Opportunity Analysis By Route of Administration, 2022-2032

Deep-dive segmentation will be available in the sample on request

8. Global Psychotropic Drugs Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2017-2021

    8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032

        8.3.1. Hospital Pharmacies

        8.3.2. Retail Pharmacies

        8.3.3. Online Pharmacies

        8.3.4. Drug Stores

    8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017-2021

    8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032

Deep-dive segmentation will be available in the sample on request

9. Global Psychotropic Drugs Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. East Asia

        9.3.5. South Asia & Pacific

        9.3.6. MEA

    9.4. Market Attractiveness Analysis By Region

10. North America Psychotropic Drugs Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. U.S.

            10.2.1.2. Canada

        10.2.2. By Drug Type

        10.2.3. By Indication

        10.2.4. By Route of Administration

        10.2.5. By Distribution Channel

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Drug Type

        10.3.3. By Indication

        10.3.4. By Route of Administration

        10.3.5. By Distribution Channel

    10.4. Key Takeaways

11. Latin America Psychotropic Drugs Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Mexico

            11.2.1.2. Brazil

            11.2.1.3. Rest of Latin America

        11.2.2. By Drug Type

        11.2.3. By Indication

        11.2.4. By Route of Administration

        11.2.5. By Distribution Channel

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Drug Type

        11.3.3. By Indication

        11.3.4. By Route of Administration

        11.3.5. By Distribution Channel

    11.4. Key Takeaways

12. Europe Psychotropic Drugs Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. Italy

            12.2.1.3. France

            12.2.1.4. U.K.

            12.2.1.5. Spain

            12.2.1.6. BENELUX

            12.2.1.7. Russia

            12.2.1.8. Rest of Europe

        12.2.2. By Drug Type

        12.2.3. By Indication

        12.2.4. By Route of Administration

        12.2.5. By Distribution Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Drug Type

        12.3.3. By Indication

        12.3.4. By Route of Administration

        12.3.5. By Distribution Channel

    12.4. Key Takeaways

13. East Asia Psychotropic Drugs Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Drug Type

        13.2.3. By Indication

        13.2.4. By Route of Administration

        13.2.5. By Distribution Channel

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Drug Type

        13.3.3. By Indication

        13.3.4. By Route of Administration

        13.3.5. By Distribution Channel

    13.4. Key Takeaways

14. South Asia & Pacific Psychotropic Drugs Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. India

            14.2.1.2. ASEAN

            14.2.1.3. Australia and New Zealand

            14.2.1.4. Rest of South Asia & Pacific

        14.2.2. By Drug Type

        14.2.3. By Indication

        14.2.4. By Route of Administration

        14.2.5. By Distribution Channel

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Drug Type

        14.3.3. By Indication

        14.3.4. By Route of Administration

        14.3.5. By Distribution Channel

    14.4. Key Takeaways

15. MEA Psychotropic Drugs Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. Turkey

            15.2.1.3. South Africa

            15.2.1.4. Rest of MEA

        15.2.2. By Drug Type

        15.2.3. By Indication

        15.2.4. By Route of Administration

        15.2.5. By Distribution Channel

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Drug Type

        15.3.3. By Indication

        15.3.4. By Route of Administration

        15.3.5. By Distribution Channel

    15.4. Key Takeaways

16. Key Countries Psychotropic Drugs Market Analysis

    16.1. U.S.

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2021

            16.1.2.1. By Drug Type

            16.1.2.2. By Indication

            16.1.2.3. By Route of Administration

            16.1.2.4. By Distribution Channel

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2021

            16.2.2.1. By Drug Type

            16.2.2.2. By Indication

            16.2.2.3. By Route of Administration

            16.2.2.4. By Distribution Channel

    16.3. Mexico

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2021

            16.3.2.1. By Drug Type

            16.3.2.2. By Indication

            16.3.2.3. By Route of Administration

            16.3.2.4. By Distribution Channel

    16.4. Brazil

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2021

            16.4.2.1. By Drug Type

            16.4.2.2. By Indication

            16.4.2.3. By Route of Administration

            16.4.2.4. By Distribution Channel

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2021

            16.5.2.1. By Drug Type

            16.5.2.2. By Indication

            16.5.2.3. By Route of Administration

            16.5.2.4. By Distribution Channel

    16.6. Italy

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2021

            16.6.2.1. By Drug Type

            16.6.2.2. By Indication

            16.6.2.3. By Route of Administration

            16.6.2.4. By Distribution Channel

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2021

            16.7.2.1. By Drug Type

            16.7.2.2. By Indication

            16.7.2.3. By Route of Administration

            16.7.2.4. By Distribution Channel

    16.8. U.K.

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2021

            16.8.2.1. By Drug Type

            16.8.2.2. By Indication

            16.8.2.3. By Route of Administration

            16.8.2.4. By Distribution Channel

    16.9. Spain

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2021

            16.9.2.1. By Drug Type

            16.9.2.2. By Indication

            16.9.2.3. By Route of Administration

            16.9.2.4. By Distribution Channel

    16.10. BENELUX

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2021

            16.10.2.1. By Drug Type

            16.10.2.2. By Indication

            16.10.2.3. By Route of Administration

            16.10.2.4. By Distribution Channel

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2021

            16.11.2.1. By Drug Type

            16.11.2.2. By Indication

            16.11.2.3. By Route of Administration

            16.11.2.4. By Distribution Channel

    16.12. China

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2021

            16.12.2.1. By Drug Type

            16.12.2.2. By Indication

            16.12.2.3. By Route of Administration

            16.12.2.4. By Distribution Channel

    16.13. Japan

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2021

            16.13.2.1. By Drug Type

            16.13.2.2. By Indication

            16.13.2.3. By Route of Administration

            16.13.2.4. By Distribution Channel

    16.14. South Korea

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2021

            16.14.2.1. By Drug Type

            16.14.2.2. By Indication

            16.14.2.3. By Route of Administration

            16.14.2.4. By Distribution Channel

    16.15. India

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2021

            16.15.2.1. By Drug Type

            16.15.2.2. By Indication

            16.15.2.3. By Route of Administration

            16.15.2.4. By Distribution Channel

    16.16. ASEAN

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2021

            16.16.2.1. By Drug Type

            16.16.2.2. By Indication

            16.16.2.3. By Route of Administration

            16.16.2.4. By Distribution Channel

    16.17. Australia and New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2021

            16.17.2.1. By Drug Type

            16.17.2.2. By Indication

            16.17.2.3. By Route of Administration

            16.17.2.4. By Distribution Channel

    16.18. GCC Countries

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2021

            16.18.2.1. By Drug Type

            16.18.2.2. By Indication

            16.18.2.3. By Route of Administration

            16.18.2.4. By Distribution Channel

    16.19. Turkey

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2021

            16.19.2.1. By Drug Type

            16.19.2.2. By Indication

            16.19.2.3. By Route of Administration

            16.19.2.4. By Distribution Channel

    16.20. South Africa

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2021

            16.20.2.1. By Drug Type

            16.20.2.2. By Indication

            16.20.2.3. By Route of Administration

            16.20.2.4. By Distribution Channel

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Drug Type

        17.3.3. By Indication

        17.3.4. By Route of Administration

        17.3.5. By Distribution Channel

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Abbott Health Care

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. Alembic Pharmaceuticals Ltd

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. Alkem Laboratories Ltd

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. Cipla Ltd

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. Dr Reddy's Laboratories Ltd

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. Fourrts India Laboratories Pvt Ltd

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. Hetero Healthcare Ltd

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. Intas Pharmaceuticals Ltd

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. Lupin Ltd

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

        18.1.10. Mankind Pharma Pvt Ltd

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

                18.1.10.5.2. Product Strategy

                18.1.10.5.3. Channel Strategy

        18.1.11. Micro Labs Ltd

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

                18.1.11.5.2. Product Strategy

                18.1.11.5.3. Channel Strategy

        18.1.12. Sun Pharmaceutical Industries Ltd

            18.1.12.1. Overview

            18.1.12.2. Product Portfolio

            18.1.12.3. Profitability by Market Segments

            18.1.12.4. Sales Footprint

            18.1.12.5. Strategy Overview

                18.1.12.5.1. Marketing Strategy

                18.1.12.5.2. Product Strategy

                18.1.12.5.3. Channel Strategy

        18.1.13. Tasmed India (P) Limited

            18.1.13.1. Overview

            18.1.13.2. Product Portfolio

            18.1.13.3. Profitability by Market Segments

            18.1.13.4. Sales Footprint

            18.1.13.5. Strategy Overview

                18.1.13.5.1. Marketing Strategy

                18.1.13.5.2. Product Strategy

                18.1.13.5.3. Channel Strategy

        18.1.14. Torrent Pharmaceuticals Ltd

            18.1.14.1. Overview

            18.1.14.2. Product Portfolio

            18.1.14.3. Profitability by Market Segments

            18.1.14.4. Sales Footprint

            18.1.14.5. Strategy Overview

                18.1.14.5.1. Marketing Strategy

                18.1.14.5.2. Product Strategy

                18.1.14.5.3. Channel Strategy

        18.1.15. Zee Laboratories Ltd

            18.1.15.1. Overview

            18.1.15.2. Product Portfolio

            18.1.15.3. Profitability by Market Segments

            18.1.15.4. Sales Footprint

            18.1.15.5. Strategy Overview

                18.1.15.5.1. Marketing Strategy

                18.1.15.5.2. Product Strategy

                18.1.15.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Psychotropic Drugs Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Psychotropic Drugs Market Value (US$ Mn) Forecast by Drug Type, 2017-2032

Table 3: Global Psychotropic Drugs Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 4: Global Psychotropic Drugs Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 5: Global Psychotropic Drugs Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 6: North America Psychotropic Drugs Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 7: North America Psychotropic Drugs Market Value (US$ Mn) Forecast by Drug Type, 2017-2032

Table 8: North America Psychotropic Drugs Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 9: North America Psychotropic Drugs Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 10: North America Psychotropic Drugs Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 11: Latin America Psychotropic Drugs Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 12: Latin America Psychotropic Drugs Market Value (US$ Mn) Forecast by Drug Type, 2017-2032

Table 13: Latin America Psychotropic Drugs Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 14: Latin America Psychotropic Drugs Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 15: Latin America Psychotropic Drugs Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 16: Europe Psychotropic Drugs Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 17: Europe Psychotropic Drugs Market Value (US$ Mn) Forecast by Drug Type, 2017-2032

Table 18: Europe Psychotropic Drugs Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 19: Europe Psychotropic Drugs Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 20: Europe Psychotropic Drugs Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 21: East Asia Psychotropic Drugs Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: East Asia Psychotropic Drugs Market Value (US$ Mn) Forecast by Drug Type, 2017-2032

Table 23: East Asia Psychotropic Drugs Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 24: East Asia Psychotropic Drugs Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 25: East Asia Psychotropic Drugs Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 26: South Asia & Pacific Psychotropic Drugs Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 27: South Asia & Pacific Psychotropic Drugs Market Value (US$ Mn) Forecast by Drug Type, 2017-2032

Table 28: South Asia & Pacific Psychotropic Drugs Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 29: South Asia & Pacific Psychotropic Drugs Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 30: South Asia & Pacific Psychotropic Drugs Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 31: MEA Psychotropic Drugs Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 32: MEA Psychotropic Drugs Market Value (US$ Mn) Forecast by Drug Type, 2017-2032

Table 33: MEA Psychotropic Drugs Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 34: MEA Psychotropic Drugs Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 35: MEA Psychotropic Drugs Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Psychotropic Drugs Market Value (US$ Mn) by Drug Type, 2022-2032

Figure 2: Global Psychotropic Drugs Market Value (US$ Mn) by Indication, 2022-2032

Figure 3: Global Psychotropic Drugs Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 4: Global Psychotropic Drugs Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 5: Global Psychotropic Drugs Market Value (US$ Mn) by Region, 2022-2032

Figure 6: Global Psychotropic Drugs Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 7: Global Psychotropic Drugs Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 8: Global Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 9: Global Psychotropic Drugs Market Value (US$ Mn) Analysis by Drug Type, 2017-2032

Figure 10: Global Psychotropic Drugs Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032

Figure 11: Global Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032

Figure 12: Global Psychotropic Drugs Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 13: Global Psychotropic Drugs Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 14: Global Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 15: Global Psychotropic Drugs Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 16: Global Psychotropic Drugs Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 17: Global Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 18: Global Psychotropic Drugs Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 19: Global Psychotropic Drugs Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 20: Global Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 21: Global Psychotropic Drugs Market Attractiveness by Drug Type, 2022-2032

Figure 22: Global Psychotropic Drugs Market Attractiveness by Indication, 2022-2032

Figure 23: Global Psychotropic Drugs Market Attractiveness by Route of Administration, 2022-2032

Figure 24: Global Psychotropic Drugs Market Attractiveness by Distribution Channel, 2022-2032

Figure 25: Global Psychotropic Drugs Market Attractiveness by Region, 2022-2032

Figure 26: North America Psychotropic Drugs Market Value (US$ Mn) by Drug Type, 2022-2032

Figure 27: North America Psychotropic Drugs Market Value (US$ Mn) by Indication, 2022-2032

Figure 28: North America Psychotropic Drugs Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 29: North America Psychotropic Drugs Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 30: North America Psychotropic Drugs Market Value (US$ Mn) by Country, 2022-2032

Figure 31: North America Psychotropic Drugs Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 32: North America Psychotropic Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 33: North America Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 34: North America Psychotropic Drugs Market Value (US$ Mn) Analysis by Drug Type, 2017-2032

Figure 35: North America Psychotropic Drugs Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032

Figure 36: North America Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032

Figure 37: North America Psychotropic Drugs Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 38: North America Psychotropic Drugs Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 39: North America Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 40: North America Psychotropic Drugs Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 41: North America Psychotropic Drugs Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 42: North America Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 43: North America Psychotropic Drugs Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 44: North America Psychotropic Drugs Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 45: North America Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 46: North America Psychotropic Drugs Market Attractiveness by Drug Type, 2022-2032

Figure 47: North America Psychotropic Drugs Market Attractiveness by Indication, 2022-2032

Figure 48: North America Psychotropic Drugs Market Attractiveness by Route of Administration, 2022-2032

Figure 49: North America Psychotropic Drugs Market Attractiveness by Distribution Channel, 2022-2032

Figure 50: North America Psychotropic Drugs Market Attractiveness by Country, 2022-2032

Figure 51: Latin America Psychotropic Drugs Market Value (US$ Mn) by Drug Type, 2022-2032

Figure 52: Latin America Psychotropic Drugs Market Value (US$ Mn) by Indication, 2022-2032

Figure 53: Latin America Psychotropic Drugs Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 54: Latin America Psychotropic Drugs Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 55: Latin America Psychotropic Drugs Market Value (US$ Mn) by Country, 2022-2032

Figure 56: Latin America Psychotropic Drugs Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 57: Latin America Psychotropic Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 58: Latin America Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 59: Latin America Psychotropic Drugs Market Value (US$ Mn) Analysis by Drug Type, 2017-2032

Figure 60: Latin America Psychotropic Drugs Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032

Figure 61: Latin America Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032

Figure 62: Latin America Psychotropic Drugs Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 63: Latin America Psychotropic Drugs Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 64: Latin America Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 65: Latin America Psychotropic Drugs Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 66: Latin America Psychotropic Drugs Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 67: Latin America Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 68: Latin America Psychotropic Drugs Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 69: Latin America Psychotropic Drugs Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 70: Latin America Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 71: Latin America Psychotropic Drugs Market Attractiveness by Drug Type, 2022-2032

Figure 72: Latin America Psychotropic Drugs Market Attractiveness by Indication, 2022-2032

Figure 73: Latin America Psychotropic Drugs Market Attractiveness by Route of Administration, 2022-2032

Figure 74: Latin America Psychotropic Drugs Market Attractiveness by Distribution Channel, 2022-2032

Figure 75: Latin America Psychotropic Drugs Market Attractiveness by Country, 2022-2032

Figure 76: Europe Psychotropic Drugs Market Value (US$ Mn) by Drug Type, 2022-2032

Figure 77: Europe Psychotropic Drugs Market Value (US$ Mn) by Indication, 2022-2032

Figure 78: Europe Psychotropic Drugs Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 79: Europe Psychotropic Drugs Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 80: Europe Psychotropic Drugs Market Value (US$ Mn) by Country, 2022-2032

Figure 81: Europe Psychotropic Drugs Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 82: Europe Psychotropic Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 83: Europe Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 84: Europe Psychotropic Drugs Market Value (US$ Mn) Analysis by Drug Type, 2017-2032

Figure 85: Europe Psychotropic Drugs Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032

Figure 86: Europe Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032

Figure 87: Europe Psychotropic Drugs Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 88: Europe Psychotropic Drugs Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 89: Europe Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 90: Europe Psychotropic Drugs Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 91: Europe Psychotropic Drugs Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 92: Europe Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 93: Europe Psychotropic Drugs Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 94: Europe Psychotropic Drugs Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 95: Europe Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 96: Europe Psychotropic Drugs Market Attractiveness by Drug Type, 2022-2032

Figure 97: Europe Psychotropic Drugs Market Attractiveness by Indication, 2022-2032

Figure 98: Europe Psychotropic Drugs Market Attractiveness by Route of Administration, 2022-2032

Figure 99: Europe Psychotropic Drugs Market Attractiveness by Distribution Channel, 2022-2032

Figure 100: Europe Psychotropic Drugs Market Attractiveness by Country, 2022-2032

Figure 101: East Asia Psychotropic Drugs Market Value (US$ Mn) by Drug Type, 2022-2032

Figure 102: East Asia Psychotropic Drugs Market Value (US$ Mn) by Indication, 2022-2032

Figure 103: East Asia Psychotropic Drugs Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 104: East Asia Psychotropic Drugs Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 105: East Asia Psychotropic Drugs Market Value (US$ Mn) by Country, 2022-2032

Figure 106: East Asia Psychotropic Drugs Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 107: East Asia Psychotropic Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 108: East Asia Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 109: East Asia Psychotropic Drugs Market Value (US$ Mn) Analysis by Drug Type, 2017-2032

Figure 110: East Asia Psychotropic Drugs Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032

Figure 111: East Asia Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032

Figure 112: East Asia Psychotropic Drugs Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 113: East Asia Psychotropic Drugs Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 114: East Asia Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 115: East Asia Psychotropic Drugs Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 116: East Asia Psychotropic Drugs Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 117: East Asia Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 118: East Asia Psychotropic Drugs Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 119: East Asia Psychotropic Drugs Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 120: East Asia Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 121: East Asia Psychotropic Drugs Market Attractiveness by Drug Type, 2022-2032

Figure 122: East Asia Psychotropic Drugs Market Attractiveness by Indication, 2022-2032

Figure 123: East Asia Psychotropic Drugs Market Attractiveness by Route of Administration, 2022-2032

Figure 124: East Asia Psychotropic Drugs Market Attractiveness by Distribution Channel, 2022-2032

Figure 125: East Asia Psychotropic Drugs Market Attractiveness by Country, 2022-2032

Figure 126: South Asia & Pacific Psychotropic Drugs Market Value (US$ Mn) by Drug Type, 2022-2032

Figure 127: South Asia & Pacific Psychotropic Drugs Market Value (US$ Mn) by Indication, 2022-2032

Figure 128: South Asia & Pacific Psychotropic Drugs Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 129: South Asia & Pacific Psychotropic Drugs Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 130: South Asia & Pacific Psychotropic Drugs Market Value (US$ Mn) by Country, 2022-2032

Figure 131: South Asia & Pacific Psychotropic Drugs Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 132: South Asia & Pacific Psychotropic Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 133: South Asia & Pacific Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 134: South Asia & Pacific Psychotropic Drugs Market Value (US$ Mn) Analysis by Drug Type, 2017-2032

Figure 135: South Asia & Pacific Psychotropic Drugs Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032

Figure 136: South Asia & Pacific Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032

Figure 137: South Asia & Pacific Psychotropic Drugs Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 138: South Asia & Pacific Psychotropic Drugs Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 139: South Asia & Pacific Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 140: South Asia & Pacific Psychotropic Drugs Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 141: South Asia & Pacific Psychotropic Drugs Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 142: South Asia & Pacific Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 143: South Asia & Pacific Psychotropic Drugs Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 144: South Asia & Pacific Psychotropic Drugs Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 145: South Asia & Pacific Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 146: South Asia & Pacific Psychotropic Drugs Market Attractiveness by Drug Type, 2022-2032

Figure 147: South Asia & Pacific Psychotropic Drugs Market Attractiveness by Indication, 2022-2032

Figure 148: South Asia & Pacific Psychotropic Drugs Market Attractiveness by Route of Administration, 2022-2032

Figure 149: South Asia & Pacific Psychotropic Drugs Market Attractiveness by Distribution Channel, 2022-2032

Figure 150: South Asia & Pacific Psychotropic Drugs Market Attractiveness by Country, 2022-2032

Figure 151: MEA Psychotropic Drugs Market Value (US$ Mn) by Drug Type, 2022-2032

Figure 152: MEA Psychotropic Drugs Market Value (US$ Mn) by Indication, 2022-2032

Figure 153: MEA Psychotropic Drugs Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 154: MEA Psychotropic Drugs Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 155: MEA Psychotropic Drugs Market Value (US$ Mn) by Country, 2022-2032

Figure 156: MEA Psychotropic Drugs Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 157: MEA Psychotropic Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 158: MEA Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 159: MEA Psychotropic Drugs Market Value (US$ Mn) Analysis by Drug Type, 2017-2032

Figure 160: MEA Psychotropic Drugs Market Value Share (%) and BPS Analysis by Drug Type, 2022-2032

Figure 161: MEA Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Drug Type, 2022-2032

Figure 162: MEA Psychotropic Drugs Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 163: MEA Psychotropic Drugs Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 164: MEA Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 165: MEA Psychotropic Drugs Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 166: MEA Psychotropic Drugs Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 167: MEA Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 168: MEA Psychotropic Drugs Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 169: MEA Psychotropic Drugs Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 170: MEA Psychotropic Drugs Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 171: MEA Psychotropic Drugs Market Attractiveness by Drug Type, 2022-2032

Figure 172: MEA Psychotropic Drugs Market Attractiveness by Indication, 2022-2032

Figure 173: MEA Psychotropic Drugs Market Attractiveness by Route of Administration, 2022-2032

Figure 174: MEA Psychotropic Drugs Market Attractiveness by Distribution Channel, 2022-2032

Figure 175: MEA Psychotropic Drugs Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Antiepileptic Drugs Market

Published : March 2017

Healthcare

Antithrombotic Drugs Market

Published : March 2017

Healthcare

Farm Animal Drugs Market

Published : July 2017

Healthcare

Anti-Viral Drugs Market

Published : October 2016

Google translate

Psychotropic Drugs Market